# New York Blood Center, Inc. – FDA Inspection, Dec 19, 2022

Source: https://www.keypedia.com/records/fda_inspections/new-york-blood-center-inc/c76cf2c4-354e-4d81-8fe6-6cb1edadedaf
Source feed: FDA_Inspections

> FDA inspection 1194222 of New York Blood Center, Inc., December 19, 2022. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1194222
- Company Name: New York Blood Center, Inc.
- Inspection Date: 2022-12-19
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1094266 - 2019-06-24
- FDA Inspection 1009901 - 2017-04-25
- FDA Inspection 903225 - 2014-11-07
- FDA Inspection 831324 - 2013-05-10
- FDA Inspection 751007 - 2011-10-19

Company: https://www.keypedia.com/companies/new-york-blood-center-inc/53394ccb-066a-4961-824a-b14316f7d768

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d